Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia

Medicine (United States)

Volumn 95, Issue 31, 2016, Pages

  Jeon, Yong Duk ^a,b   Jeong, Woo Yong ^a   Kim, Moo Hyun ^a   Jung, In Young ^a   Ahn, Mi Young ^a,b   Ann, Hea Won ^a,b   Ahn, Jin Young ^a,b   Han, Sang Hoon ^a,b   Choi, Jun Yong ^a,b   Song, Young Goo ^a,b   Kim, June Myung ^a,b   Ku, Nam Su ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

bacteremia; central venous catheter; mortality; risk factor; Stenotrophomonas maltophilia

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; LEVOFLOXACIN;

ACINETOBACTER; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTEREMIA; CANDIDA; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; ENTEROCOCCUS; FEMALE; GRAM NEGATIVE INFECTION; HEALTHCARE ASSOCIATED INFECTION; HEMATOLOGIC MALIGNANCY; HEPATOBILIARY SYSTEM INFECTION; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY RATE; PRIMARY INFECTION; PRIORITY JOURNAL; PSEUDOMONAS; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SERRATIA; SOLID TUMOR; SOUTH KOREA; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL RATE; ADVERSE EFFECTS; AGE; BLADDER CATHETERIZATION; CAUSE OF DEATH; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; FACTUAL DATABASE; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL MODEL; SURVIVAL ANALYSIS;

ADULT; AGE FACTORS; AGED; CATHETERIZATION, CENTRAL VENOUS; CAUSE OF DEATH; COHORT STUDIES; CROSS INFECTION; DATABASES, FACTUAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL ANALYSIS; URINARY CATHETERIZATION;

EID: 84983315586     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004375     Document Type: Article

References (27)

1. Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009;9:312-23.
2. Demiraslan H, Sevim M, Pala C, et al. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol 2013;97:414-20.
3. del Toro MD, Rodriguez-Bano J, Herrero M, et al. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine 2002;81:228-39.
4. XunM, Zhang Y, Li BL, et al. Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China. J Infect Dev Ctries 2014;8:1000-5.
5. Senol E, DesJardin J, Stark PC, et al. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 2002;34: 1653-6.
6. Wang WS, Liu CP, Lee CM, et al. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004;37:359-65.
7. Cho SY, Kang CI, Kim J, et al. Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Antimicrob Agents Chemother 2014;58: 581-3.
8. Wang YL, Scipione MR, Dubrovskaya Y, et al. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother 2014;58:176-82.
9. Falagas ME, Kastoris AC, Vouloumanou EK, et al. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 2009;4:1103-9.
10. Garazi M, Singer C, Tai J, et al. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect 2012;81:114-8.
11. Paez JI, Tengan FM, Barone AA, et al. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 2008;27:901-6.
12. Kwa AL, Low JG, Lim TP, et al. Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures. Ann Acad Med Singapore 2008;37:826-30.
13. Hotta G, Matsumura Y, Kato K, et al. Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PLoS One 2014;9:e112208.
14. Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 2008;70:101-8.
15. Araoka H, Baba M, Yoneyama A. Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis 2010;29:605-8.
16. Cheong HS, Lee JA, Kang CI, et al. Risk factors for mortality and clinical implications of catheter-related infections in patients with bacteraemia caused by Stenotrophomonas maltophilia. Int J Antimicrob Agents 2008;32:538-40.
17. Cho SY, Lee DG, Choi SM, et al. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations. BMC Infect Dis 2015;15:69.
18. Fihman V, Le Monnier A, Corvec S, et al. Stenotrophomonasmaltophilia-the most worrisome threat among unusual non-fermentative gramnegative bacilli from hospitalized patients: a prospective multicenter study. J Infect 2012;64:391-8.
19. Lai CH, Wong WW, Chin C, et al. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect 2006;12:986-91.
20. Lakatos B, Jakopp B, Widmer A, et al. Evaluation of treatment outcomes for Stenotrophomonas maltophilia bacteraemia. Infection 2014;42: 553-8.
21. Kang CI, Kim SH, Park WB, et al. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004;48:4574-81.
22. Lai CH, Chi CY, Chen HP, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 2004;37:350-8.
23. Samonis G, Karageorgopoulos DE, Maraki S, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One 2012;7: e37375.
24. Friedman ND, Korman TM, Fairley CK, et al. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 2002;45:47-53.
25. Metan G, Uzun O. Impact of initial antimicrobial therapy in patientswith bloodstream infections caused by Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2005;49:3980-1.
26. Boktour M, Hanna H, Ansari S, et al. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 2006;106:1967-73.
27. Kierzkowska M, Majewska A, Dobrzaniecka K, et al. Blood infections in patients treated at transplantationwards of a clinical hospital inWarsaw. Transplant Proc 2014;46:2589-91.